Vaccines

Vaccines Public Health Vaccines Vaccination Health Policy Immunology Clinical Trials Pharmaceuticals Immunology Regulatory Affairs

3 ARTICLES

5d ago

FDA Advisers Back JN.1-Based COVID Boosters for Fall Amid New Access Rules

The panel's unanimous vote coincides with new FDA policies restricting booster eligibility for healthy individuals under 65 without additional trials.

23 ARTICLES

5d ago

HHS and NIH Launch $500 Million Universal Vaccine Initiative Using Whole-Virus Approach

4 ARTICLES

4w ago

FDA Demands New Trials for Novavax COVID Vaccine, Raising Concerns Over Fall Booster Rollouts

3 ARTICLES

4w ago

Merck Lowers 2025 Profit Forecast as Tariffs and Licensing Costs Weigh

3 ARTICLES

last mo.

Federal Vaccine Panel Expands RSV, Meningitis, and Chikungunya Recommendations

3 ARTICLES

last mo.

John Rich's Advice to Trump Shaped Vaccine Messaging Strategy

8 ARTICLES

last mo.

Shingles Vaccine Linked to 20% Reduction in Dementia Risk, Study Finds

3 ARTICLES

last mo.

NICE Approves Brentuximab Vedotin for Advanced Hodgkin Lymphoma on NHS

3 ARTICLES

2mo ago

Linda McMahon Addresses Potential Shift in Vaccine Policy Oversight and RFK Jr.'s Role

3 ARTICLES

2mo ago

NIH Directs Scientists to Remove mRNA Vaccine References, Raising Fears of Research Cuts

3 ARTICLES

2mo ago

Vaxart's Oral Norovirus Vaccine Shows Promise in Early Trials for Elderly Adults

30 ARTICLES

2mo ago

FDA and CDC Vaccine Meetings Canceled, Raising Concerns Over Flu Shot Supply and Transparency

3 ARTICLES

2mo ago

Novavax Reports Narrower Q4 Loss and Strategic Shift Away from COVID-19 Vaccine Commercialization

6 ARTICLES

3mo ago

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet

6 ARTICLES

3mo ago

Sen. Susan Collins Backs RFK Jr. for Health Secretary Amid Widespread Criticism

Particle.news

Vaccines

FDA Advisers Back JN.1-Based COVID Boosters for Fall Amid New Access Rules

FDA Expands Heart Risk Warnings for Pfizer and Moderna COVID-19 Vaccines

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine

HHS Implements Controversial Vaccine Trial Mandate Under RFK Jr.

Shingles Vaccine Found to Reduce Cardiovascular Risks by Up to 26%

HHS and NIH Launch $500 Million Universal Vaccine Initiative Using Whole-Virus Approach

FDA Demands New Trials for Novavax COVID Vaccine, Raising Concerns Over Fall Booster Rollouts

Merck Lowers 2025 Profit Forecast as Tariffs and Licensing Costs Weigh

Federal Vaccine Panel Expands RSV, Meningitis, and Chikungunya Recommendations

Never miss stories about

Vaccines

John Rich's Advice to Trump Shaped Vaccine Messaging Strategy

Shingles Vaccine Linked to 20% Reduction in Dementia Risk, Study Finds

NICE Approves Brentuximab Vedotin for Advanced Hodgkin Lymphoma on NHS

Linda McMahon Addresses Potential Shift in Vaccine Policy Oversight and RFK Jr.'s Role

NIH Directs Scientists to Remove mRNA Vaccine References, Raising Fears of Research Cuts

Vaxart's Oral Norovirus Vaccine Shows Promise in Early Trials for Elderly Adults

FDA and CDC Vaccine Meetings Canceled, Raising Concerns Over Flu Shot Supply and Transparency

Novavax Reports Narrower Q4 Loss and Strategic Shift Away from COVID-19 Vaccine Commercialization

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet

Sen. Susan Collins Backs RFK Jr. for Health Secretary Amid Widespread Criticism

Never miss stories about

Vaccines